Novartis Investigator Site

Milwaukee, Wisconsin 53209

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Cardiovascular Events Clinical Trial
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
Status: Enrolling, Phase III
Updated: 8/29/2013
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Chronic Heart Failure (CHF) Clinical Trial
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Milwaukee, WI
Click here to add this to my saved trials